John Nicholson - Net Worth and Insider Trading
John Nicholson Net Worth
The estimated net worth of John Nicholson is at least $205,076 dollars as of 2024-04-20. John Nicholson is the SVP & COO of Nektar Therapeutics and owns about 162,759 shares of Nektar Therapeutics (NKTR) stock worth over $205,076. Details can be seen in John Nicholson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John Nicholson has not made any transactions after 2019-08-16 and currently still holds the listed stock(s).
Transaction Summary of John Nicholson
John Nicholson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Nicholson owns 1 companies in total, including Nektar Therapeutics (NKTR) .
Click here to see the complete history of John Nicholson’s form 4 insider trades.
Insider Ownership Summary of John Nicholson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2019-08-16 | SVP & Chief Operating Officer |
John Nicholson Latest Holdings Summary
John Nicholson currently owns a total of 1 stock. John Nicholson owns 162,759 shares of Nektar Therapeutics (NKTR) as of August 16, 2019, with a value of $205,076.
Latest Holdings of John Nicholson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2019-08-16 | 162,759 | 1.26 | 205,076 |
Holding Weightings of John Nicholson
John Nicholson Form 4 Trading Tracker
According to the SEC Form 4 filings, John Nicholson has made a total of 2 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Nektar Therapeutics is the sale of 3,819 shares on August 16, 2019, which brought John Nicholson around $69,315.
Insider Trading History of John Nicholson
- 1
John Nicholson Trading Performance
John Nicholson Ownership Network
Ownership Network List of John Nicholson
Ownership Network Relation of John Nicholson
John Nicholson Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
John Nicholson is the SVP & Chief Operating Officer of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, John Nicholson made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 137,918 shares made by Howard W Robin , a net sale of 62,098 shares made by Jonathan Zalevsky , and a net sale of 46,514 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 36,653 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 36,653 shares. During the past 18 months, 276,610 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 276,610 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
John Nicholson Mailing Address
Above is the net worth, insider trading, and ownership report for John Nicholson. You might contact John Nicholson via mailing address: C/o Nektar Therapeutics, 201 Industrial Road, San Carlos Ca 94070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
